5.000USD-1.96%Mkt Cap: 516.62M $P/E: —2d ago
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to h…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Cheaper
1M Perf
Avg
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
Indicators:|
Key Statistics
Company
Market Cap516.62M $
Enterprise Value280.97M $
Revenue (TTM)594.41M $
Gross Profit302.24M $
Net Income (TTM)-291.54M $
Revenue/Share5.495 USD
Last Price5.000 USD
Fiscal Year EndDec 2024
MR QuarterSep 2022
Employees2.3K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.80
PEG1.95
EV/EBITDA-3.84
EV/Revenue0.47
P/S0.87
P/B0.64
EPS (TTM)-2.70
EPS (Forward)0.30
52W Range
3.00067% of range6.000
52W High6.000 USD
52W Low3.000 USD
Profitability
Gross Margin50.85%
Oper. Margin16.59%
EBITDA Margin-12.31%
Profit Margin-49.05%
ROE-31.05%
ROA-3.69%
Growth
Revenue Growth5.00%
Earnings Growth-1.80%
Cash Flow & Leverage
Operating CF115.56M $
CapEx (TTM)32.27M $
FCF Margin2.61%
FCF Yield3.00%
Net Debt-273.79M $
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity0.22
Current Ratio1.29
Quick Ratio1.17
Book Value/Sh7.428 USD
Cash/Share4.520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateOct 7, 2008
Pay DateOct 17, 2008
Analyst Consensus
Rating—
Target (Mean)6.500 USD
Upside (mean)+30.0%
Target Range5.000 USD – 8.000 USD
$5.000+30.0% to mean$8.000
# Analysts2
Ownership
Shares Out.108.99M
Float52.13M
Insiders4.43%
Institutions66.00%
Short Interest
Short Ratio3.9d
Shares Short8.13M
Short (prev mo.)9.43M
Technical
SMA 504.788 (+4.4%)
SMA 2004.697 (+6.4%)
Beta0.54
S&P 52W Chg20.05%
Avg Vol (30d)72.20K
Avg Vol (10d)49.92K
Technical Indicators
RSI (14)54.0
MACD0.0666
MACD Signal0.0610
MACD Hist.+0.0056
BB Upper5.258 USD
BB Middle4.938 USD
BB Lower4.617 USD
BB Width13.00%
ATR (14)0.3454 USD
Vol Ratio (20d)0.35x